PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “DICHLORPHENAMIDE”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 127 records · Page 7Linked to original sources
PubMed1991

[Diclofenamide Reference Standard (Control 891) of National Institute of Hygienic Sciences].

Quality of the raw material of diclofenamide was evaluated for preparation of "Diclofenamide Reference Standard". Analytical results for the sample were as follows: melting point 240 degrees C (decomposition); UV spectrum indicates absorption maxima at 286 and 295 nm and the absorption ratio A286/A295 1.04; IR spectrum is same as that of the USP Reference Standard; no impurity was found by TLC, but a trace of one was found by HPLC analysis; the purity is assumed to be 99.95% by HPLC analysis; loss on drying 0.1%; assay by HPLC against USP Reference Standard 100.2%. Based on the results, the present raw material was authorized to be the Reference Standard of the National Institute of Hygienic Sciences.

Chromatography, High Pressure Liquid↗
PubMed2005

[Diclofenamide].

Explore the source record for details and available documents.

Animals↗
PubMed1988

[Therapy of paroxysmal hypokalemic paralysis: experience with diclofenamid].

A case of familial hypokalemic periodic paralysis is discussed in a boy whose first paralysis occurred at 11 years of age. At first the paralysis was controlled by acetazolamid and potassium therapy. Later, frequent attacks of paralysis and muscle weakness developed necessitating a change of therapy. Diclofenamid has now already been administered for 2 years. It is well tolerated and has suppressed further attacks.

Child↗
PubMedDate not supplied

Diclofenamide in the treatment of therapy-resistant epilepsy.

An average daily dose of 33 mg of diclofenamide, a carbonic-anhydrase inhibitor, was added to the anti-epileptic medication already employed in 105 cases of severe epilepsy which had shown insufficient clinical improvement. A favourable action on seizures, often accompanied by an improvement in the EEG tracing, was observed in 83 cases. The effect was of long duration in 47 cases in that it lasted for more than a year. It persisted for one to twelve months in a further 17 cases, while in 19 patients, who had reacted favourably to the treatment, medication had to be suspended because of intolerance.

Adolescent↗
PubMed1974

Cor pulmonale.

Explore the source record for details and available documents.

Adrenal Cortex Hormones↗